---
title: "Prediabetes remission as a life-course strategy for Type 2 diabetes prevention"
id: "nature-0-type-2-diabetes-prevention-across-the-life-course"
canonical_url: "https://medichelpline.com/clinical-feed/nature-0-type-2-diabetes-prevention-across-the-life-course"
content_type: "clinical_feed_article"
specialty: "Endocrinology"
source_name: "Nature Medicine"
source_url: "https://www.nature.com/articles/s41591-026-04550-z"
published_at: "2026-08-10T09:02:03.000Z"
evidence_level: "Journal Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Prediabetes remission as a life-course strategy for Type 2 diabetes prevention
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/nature-0-type-2-diabetes-prevention-across-the-life-course
- **Specialty:** [Endocrinology](https://medichelpline.com/clinical-feed/endocrinology.md)
- **Primary Source:** Nature Medicine
- **Source URL:** [Original Journal Publication](https://www.nature.com/articles/s41591-026-04550-z)
- **Published At:** 2026-08-10T09:02:03.000Z
- **Evidence Rating:** Journal Feed
## Executive GIST (TL;DR)
- The authors propose reframing Type 2 diabetes (T2D) prevention to focus on **prediabetes remission**, aiming to preserve or restore **normoglycemia** rather than intervening only after dysglycemia is established. - T2D development is described as a progressive transition from normoglycemia through increasing dysglycemia to overt disease, influenced cumulatively by biological, behavioral and environmental exposures across the life course. - The perspective presents a **life-course risk architecture** that integrates developmental, transitional and contextual determinants and identifies windows of amplified metabolic vulnerability where restoration of normoglycemia may be possible. - **Prediabetes (intermediate hyperglycemia) remission** is framed as an achievable, pragmatic and measurable prevention target with potential long-term cardiometabolic benefits (figure referenced in source). - The authors argue for **precision prevention** that addresses mechanistic heterogeneity in T2D pathogenesis and that aligns interventions to be scalable, affordable and adaptable across socioeconomic contexts. - A set of ten priorities for T2D prevention is proposed to move beyond traditional approaches toward context-specific, actionable interventions that can alter disease natural history early in life. - Figures in the article illustrate long-term cardiometabolic benefits associated with prediabetes remission and depict life-course accumulated diabetes risk; specific data and quantitative results were not reported in the available preview. - The article situates its recommendations within broader evidence and guideline contexts, citing global prevalence and burden reports and professional guidance, but full methodological or evidence details are not available in the preview.
## Clinical Analysis & Structured Key Points
## Your privacy, your choice We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media, as well as to allow video information to be shared for both marketing, analytics and editorial purposes. By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection. See our [privacy policy](https://www.nature.com/info/privacy) for more information on the use of your personal data. Manage preferences for further information and to change your choices. Accept all cookies Reject optional cookies [Skip to main content](https://www.nature.com/articles/s41591-026-04550-z#content) Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript. Advertisement [ ![Nature Medicine](https://media.springernature.com/full/nature-cms/uploads/product/nm/header-95e59e63930e5d6009bad2c23a42ab2d.svg) ](https://www.nature.com/nm) * [ View all journals ](https://www.nature.com/siteindex) * [ Saved research ](https://www.nature.com/saved-research) * [ Search ](javascript:;) ## Search Search articles by subject, keyword or author Show results from All journals This journal Search [ Advanced search ](https://www.nature.com/search/advanced) ### Quick links * [Explore articles by subject](https://www.nature.com/subjects) * [Find a job](https://www.nature.com/naturecareers) * [Guide to authors](https://www.nature.com/authors/index.html) * [Editorial policies](https://www.nature.com/authors/editorial_policies/) * [Log in](https://idp.nature.com/auth/personal/springernature?redirect_uri=https://www.nature.com/articles/s41591-026-04550-z) * [ Content Explore content ](javascript:;) ## Explore content * [ Research articles ](https://www.nature.com/nm/research-articles) * [ Reviews & Analysis ](https://www.nature.com/nm/reviews-and-analysis) * [ News & Comment ](https://www.nature.com/nm/news-and-comment) * [ Podcasts ](https://www.nature.com/nm/podcast) * [ Current issue ](https://www.nature.com/nm/current-issue) * [ Collections ](https://www.nature.com/nm/collections) * [Follow us on Facebook ](https://www.facebook.com/Nature-Medicine-193691346949/) * [Follow us on X ](https://twitter.com/naturemedicine) * [ Subscribe ](https://www.nature.com/nm/subscribe) * [Sign up for alerts ](https://journal-alerts.springernature.com/subscribe?journal_id=41591) * [ RSS feed ](https://www.nature.com/nm.rss) * [ About the journal ](javascript:;) ## About the journal * [ Aims & Scope ](https://www.nature.com/nm/aims) * [ Journal Information ](https://www.nature.com/nm/journal-information) * [ Journal Metrics ](https://www.nature.com/nm/journal-impact) * [ About the Editors ](https://www.nature.com/nm/editors) * [ Research Cross-Journal Editorial Team ](https://www.nature.com/nm/research-cross-journal-editorial-team) * [ Reviews Cross-Journal Editorial Team ](https://www.nature.com/nm/reviews-cross-journal-editorial-team) * [ Statistical Advisory Panel ](https://www.nature.com/nm/statistics-advisory-panel) * [ Our publishing models ](https://www.nature.com/nm/our-publishing-models) * [ Editorial Values Statement ](https://www.nature.com/nm/editorial-values-statement) * [ Editorial Policies ](https://www.nature.com/nm/editorial-policies) * [ Content Types ](https://www.nature.com/nm/content) * [ Web Feeds ](https://www.nature.com/nm/web-feeds) * [ Contact ](https://www.nature.com/nm/contact) * [ Publish with us ](javascript:;) ## Publish with us * [ Submission Guidelines ](https://www.nature.com/nm/submission-guidelines) * [ For Reviewers ](https://www.nature.com/nm/for-reviewers) * [ Language editing services ](https://authorservices.springernature.com/go/sn/?utm_source=For+Authors&utm_medium=Website_Nature&utm_campaign=Platform+Experimentation+2022&utm_id=PE2022) * [Open access funding](https://www.nature.com/nm/open-access-funding) * [Submit manuscript ](https://mts-nmed.nature.com/cgi-bin/main.plex) * [ Subscribe ](https://www.nature.com/nm/subscribe) * [ Sign up for alerts ](https://journal-alerts.springernature.com/subscribe?journal_id=41591) * [ RSS feed ](https://www.nature.com/nm.rss) 1. [nature](https://www.nature.com/) 2. [nature medicine](https://www.nature.com/nm) 3. [perspectives](https://www.nature.com/nm/articles?type=perspective) 4. article * Perspective * Published: 10 August 2026 # Type 2 diabetes prevention across the life course * [Yiying Wang](https://www.nature.com/articles/s41591-026-04550-z#auth-Yiying-Wang-Aff1-Aff2-Aff3)[1](https://www.nature.com/articles/s41591-026-04550-z#Aff1),[2](https://www.nature.com/articles/s41591-026-04550-z#Aff2),[3](https://www.nature.com/articles/s41591-026-04550-z#Aff3), * [Jennifer L. Sargent](https://www.nature.com/articles/s41591-026-04550-z#auth-Jennifer_L_-Sargent-Aff4-Aff5) [ORCID: orcid.org/0009-0008-3697-1737](https://orcid.org/0009-0008-3697-1737)[4](https://www.nature.com/articles/s41591-026-04550-z#Aff4),[5](https://www.nature.com/articles/s41591-026-04550-z#Aff5), * [Chantal Mathieu](https://www.nature.com/articles/s41591-026-04550-z#auth-Chantal-Mathieu-Aff6)[6](https://www.nature.com/articles/s41591-026-04550-z#Aff6), * [Elsa Vazquez-Arreola](https://www.nature.com/articles/s41591-026-04550-z#auth-Elsa-Vazquez_Arreola-Aff7) [ORCID: orcid.org/0000-0003-1960-1159](https://orcid.org/0000-0003-1960-1159)[7](https://www.nature.com/articles/s41591-026-04550-z#Aff7), * [Leigh Perreault](https://www.nature.com/articles/s41591-026-04550-z#auth-Leigh-Perreault-Aff8) [ORCID: orcid.org/0000-0002-1481-7535](https://orcid.org/0000-0002-1481-7535)[8](https://www.nature.com/articles/s41591-026-04550-z#Aff8), * [Ruth J. F. Loos](https://www.nature.com/articles/s41591-026-04550-z#auth-Ruth_J__F_-Loos-Aff9-Aff10) [ORCID: orcid.org/0000-0002-8532-5087](https://orcid.org/0000-0002-8532-5087)[9](https://www.nature.com/articles/s41591-026-04550-z#Aff9),[10](https://www.nature.com/articles/s41591-026-04550-z#Aff10), * [Lee-Ling Lim](https://www.nature.com/articles/s41591-026-04550-z#auth-Lee_Ling-Lim-Aff11) [ORCID: orcid.org/0000-0002-6214-6924](https://orcid.org/0000-0002-6214-6924)[11](https://www.nature.com/articles/s41591-026-04550-z#Aff11), * [Leontine Sandforth](https://www.nature.com/articles/s41591-026-04550-z#auth-Leontine-Sandforth-Aff1-Aff2-Aff3)[1](https://www.nature.com/articles/s41591-026-04550-z#Aff1),[2](https://www.nature.com/articles/s41591-026-04550-z#Aff2),[3](https://www.nature.com/articles/s41591-026-04550-z#Aff3), * [Robert L. Hanson](https://www.nature.com/articles/s41591-026-04550-z#auth-Robert_L_-Hanson-Aff7)[7](https://www.nature.com/articles/s41591-026-04550-z#Aff7), * [Stephanie Kullmann](https://www.nature.com/articles/s41591-026-04550-z#auth-Stephanie-Kullmann-Aff1-Aff2-Aff3) [ORCID: orcid.org/0000-0001-9951-923X](https://orcid.org/0000-0001-9951-923X)[1](https://www.nature.com/articles/s41591-026-04550-z#Aff1),[2](https://www.nature.com/articles/s41591-026-04550-z#Aff2),[3](https://www.nature.com/articles/s41591-026-04550-z#Aff3), * [Julia Sbierski-Kind](https://www.nature.com/articles/s41591-026-04550-z#auth-Julia-Sbierski_Kind-Aff1-Aff2-Aff3-Aff12) [ORCID: orcid.org/0000-0001-7133-5332](https://orcid.org/0000-0001-7133-5332)[1](https://www.nature.com/articles/s41591-026-04550-z#Aff1),[2](https://www.nature.com/articles/s41591-026-04550-z#Aff2),[3](https://www.nature.com/articles/s41591-026-04550-z#Aff3),[12](https://www.nature.com/articles/s41591-026-04550-z#Aff12), * [Sara Y. Brucker](https://www.nature.com/articles/s41591-026-04550-z#auth-Sara_Y_-Brucker-Aff13)[13](https://www.nature.com/articles/s41591-026-04550-z#Aff13), * [Martin Hrabé de Angelis](https://www.nature.com/articles/s41591-026-04550-z#auth-Martin-Hrab__de_Angelis-Aff3-Aff14-Aff15) [ORCID: orcid.org/0000-0002-7898-2353](https://orcid.org/0000-0002-7898-2353)[3](https://www.nature.com/articles/s41591-026-04550-z#Aff3),[14](https://www.nature.com/articles/s41591-026-04550-z#Aff14),[15](https://www.nature.com/articles/s41591-026-04550-z#Aff15), * [Fabian Theiss](https://www.nature.com/articles/s41591-026-04550-z#auth-Fabian-Theiss-Aff16) [ORCID: orcid.org/0000-0002-2419-1943](https://orcid.org/0000-0002-2419-1943)[16](https://www.nature.com/articles/s41591-026-04550-z#Aff16), * [Andrea Icks](https://www.nature.com/articles/s41591-026-04550-z#auth-Andrea-Icks-Aff3-Aff17-Aff18) [ORCID: orcid.org/0000-0002-4882-969X](https://orcid.org/0000-0002-4882-969X)[3](https://www.nature.com/articles/s41591-026-04550-z#Aff3),[17](https://www.nature.com/articles/s41591-026-04550-z#Aff17),[18](https://www.nature.com/articles/s41591-026-04550-z#Aff18), * [Damon Mohebbi](https://www.nature.com/articles/s41591-026-04550-z#auth-Damon-Mohebbi-Aff17-Aff19-Aff20)[17](https://www.nature.com/articles/s41591-026-04550-z#Aff17),[19](https://www.nature.com/articles/s41591-026-04550-z#Aff19),[20](https://www.nature.com/articles/s41591-026-04550-z#Aff20), * [Norbert Stefan](https://www.nature.com/articles/s41591-026-04550-z#auth-Norbert-Stefan-Aff1-Aff2-Aff3) [ORCID: orcid.org/0000-0002-2186-9595](https://orcid.org/0000-0002-2186-9595)[1](https://www.nature.com/articles/s41591-026-04550-z#Aff1),[2](https://www.nature.com/articles/s41591-026-04550-z#Aff2),[3](https://www.nature.com/articles/s41591-026-04550-z#Aff3), * [Viswanathan Mohan](https://www.nature.com/articles/s41591-026-04550-z#auth-Viswanathan-Mohan-Aff21) [ORCID: orcid.org/0000-0001-5038-6210](https://orcid.org/0000-0001-5038-6210)[21](https://www.nature.com/articles/s41591-026-04550-z#Aff21), * [Tiange Wang](https://www.nature.com/articles/s41591-026-04550-z#auth-Tiange-Wang-Aff22) [ORCID: orcid.org/0000-0003-0723-489X](https://orcid.org/0000-0003-0723-489X)[22](https://www.nature.com/articles/s41591-026-04550-z#Aff22), * [Hubert Preissl](https://www.nature.com/articles/s41591-026-04550-z#auth-Hubert-Preissl-Aff1-Aff2-Aff3) [ORCID: orcid.org/0000-0002-8859-4661](https://orcid.org/0000-0002-8859-4661)[1](https://www.nature.com/articles/s41591-026-04550-z#Aff1),[2](https://www.nature.com/articles/s41591-026-04550-z#Aff2),[3](https://www.nature.com/articles/s41591-026-04550-z#Aff3), * [Michael Bergman](https://www.nature.com/articles/s41591-026-04550-z#auth-Michael-Bergman-Aff23) [ORCID: orcid.org/0000-0003-2589-2976](https://orcid.org/0000-0003-2589-2976)[23](https://www.nature.com/articles/s41591-026-04550-z#Aff23), * [Jaakko Tuomilehto](https://www.nature.com/articles/s41591-026-04550-z#auth-Jaakko-Tuomilehto-Aff24)[24](https://www.nature.com/articles/s41591-026-04550-z#Aff24), * [Marie-France Hivert](https://www.nature.com/articles/s41591-026-04550-z#auth-Marie_France-Hivert-Aff25-Aff26) [ORCID: orcid.org/0000-0001-7752-2585](https://orcid.org/0000-0001-7752-2585)[25](https://www.nature.com/articles/s41591-026-04550-z#Aff25),[26](https://www.nature.com/articles/s41591-026-04550-z#Aff26), * [Paul W. Franks](https://www.nature.com/articles/s41591-026-04550-z#auth-Paul_W_-Franks-Aff27-Aff28) [ORCID: orcid.org/0000-0002-0520-7604](https://orcid.org/0000-0002-0520-7604)[27](https://www.nature.com/articles/s41591-026-04550-z#Aff27),[28](https://www.nature.com/articles/s41591-026-04550-z#Aff28) & * … * [Andreas L. Birkenfeld](https://www.nature.com/articles/s41591-026-04550-z#auth-Andreas_L_-Birkenfeld-Aff1-Aff2-Aff3-Aff29) [ORCID: orcid.org/0000-0003-1407-9023](https://orcid.org/0000-0003-1407-9023)[1](https://www.nature.com/articles/s41591-026-04550-z#Aff1),[2](https://www.nature.com/articles/s41591-026-04550-z#Aff2),[3](https://www.nature.com/articles/s41591-026-04550-z#Aff3),[29](https://www.nature.com/articles/s41591-026-04550-z#Aff29) Show authors [_Nature Medicine_](https://www.nature.com/nm) (2026) [Cite this article](https://www.nature.com/articles/s41591-026-04550-z#citeas) [ Save article ](https://www.nature.com/articles/s41591-026-04550-z/save-research?_csrf=UHTdwnVE0vAuo4dDjUeqNGB_1fjVlVdR) [ View saved research ](https://www.nature.com/saved-research) ## Abstract Type 2 diabetes (T2D) prevention efforts have largely focused on intervening when dysglycemia is already established. We propose that T2D prevention be reframed around prediabetes remission, with preservation and restoration of normoglycemia as the optimal clinical goal. The transition from normoglycemia through increasing dysglycemia to T2D is progressive and cumulatively shaped by biological, behavioral and environmental exposures across the life course. Prediabetes (intermediate hyperglycemia) remission is an achievable, pragmatic and measurable prevention target. Here we provide a life-course risk architecture for T2D integrating developmental, transitional and contextual determinants, defining critical windows of amplified metabolic vulnerability and potential restoration of normoglycemia. Precision prevention should target mechanistic heterogeneity, with aligned interventions that remain scalable, affordable and adaptable across socioeconomic settings. Our framework identifies ten priorities in T2D prevention, moving beyond traditional approaches toward context-specific, actionable interventions capable of altering the natural history of disease early in the life course and restoring metabolic health. This is a preview of subscription content, [access via your institution](https://wayf.springernature.com?redirect_uri=https%3A%2F%2Fwww.nature.com%2Farticles%2Fs41591-026-04550-z) ## Access options [ Access through your institution ](https://wayf.springernature.com?redirect_uri=https%3A%2F%2Fwww.nature.com%2Farticles%2Fs41591-026-04550-z) Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 27,99 € / 30 days cancel any time [Learn more](https://shop.nature.com/products/plus/?region=ROW) Subscribe to this journal Receive 12 print issues and online access 251,40 € per year only 20,95 € per issue [Learn more](https://www.nature.com/nm/subscribe) Buy this article * Purchase on SpringerLink * Instant access to the full article PDF. 39,95 € Prices may be subject to local taxes which are calculated during checkout ### Additional access options: * [Log in](https://idp.nature.com/authorize/natureuser?client_id=grover&redirect_uri=https%3A%2F%2Fwww.nature.com%2Farticles%2Fs41591-026-04550-z) * [Learn about institutional subscriptions](https://www.springernature.com/gp/librarians/licensing/license-options) * [Read our FAQs](https://support.nature.com/en/support/home) * [Contact customer support](https://www.springernature.com/gp/contact) **Fig. 1: Long-term cardiometabolic benefits associated with prediabetes remission.** ![](https://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fs41591-026-04550-z/MediaObjects/41591_2026_4550_Fig1_HTML.png) **Fig. 2: Life-course accumulated diabetes risk.** ![](https://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fs41591-026-04550-z/MediaObjects/41591_2026_4550_Fig2_HTML.png) ## References 1. Genitsaridi, I. et al. 11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050. _Lancet Diabetes Endocrinol._ **14** , 149–156 (2025). 2. Chen, S. et al. The global macroeconomic burden of diabetes mellitus. _Nat. Med._ **32** , 126–138 (2025). [Article](https://doi.org/10.1038%2Fs41591-025-04027-5) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=41466063) [PubMed Central](http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12823416) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=The%20global%20macroeconomic%20burden%20of%20diabetes%20mellitus&journal=Nat.%20Med.&doi=10.1038%2Fs41591-025-04027-5&volume=32&pages=126-138&publication_year=2025&author=Chen%2CS) 3. WHO. Everyday actions for better health - WHO recommendations. _WHO_ [https://www.who.int/europe/news-room/fact-sheets/item/everyday-actions-for-better-health-who-recommendations](http://www.who.int/europe/news-room/fact-sheets/item/everyday-actions-for-better-health-who-recommendations) (2025). 4. WHO. WHO guidelines on physical activity and sedentary behaviour. _WHO_ [https://www.who.int/publications/i/item/9789240015128](http://www.who.int/publications/i/item/9789240015128) (2020). 5. American Diabetes Association Professional Practice Committee for Diabetes. 8. Obesity and Weight Management for the Prevention and Treatment of Diabetes: Standards of Care in Diabetes-2026. _Diabetes Care_ **49** , S166–S182 (2026). [Article](https://doi.org/10.2337%2Fdc26-S008) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=8.%20Obesity%20and%20Weight%20Management%20for%20the%20Prevention%20and%20Treatment%20of%20Diabetes%3A%20Standards%20of%20Care%20in%20Diabetes-2026&journal=Diabetes%20Care&doi=10.2337%2Fdc26-S008&volume=49&pages=S166-S182&publication_year=2026) 6. DECODE Study Group. Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. _Diabetes Care_ **26** , 61–69 (2003). [Article](https://doi.org/10.2337%2Fdiacare.26.1.61) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=Age-%20and%20sex-specific%20prevalences%20of%20diabetes%20and%20impaired%20glucose%20regulation%20in%2013%20European%20cohorts&journal=Diabetes%20Care&doi=10.2337%2Fdiacare.26.1.61&volume=26&pages=61-69&publication_year=2003) 7. Abdul-Ghani, M. A., Tripathy, D. & DeFronzo, R. A. Contributions of β-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. _Diabetes Care_ **29** , 1130–1139 (2006). [Article](https://doi.org/10.2337%2Fdc05-2179) [CAS](https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD28XkvVKqu74%3D) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16644654) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=Contributions%20of%20%CE%B2-cell%20dysfunction%20and%20insulin%20resistance%20to%20the%20pathogenesis%20of%20impaired%20glucose%20tolerance%20and%20impaired%20fasting%20glucose&journal=Diabetes%20Care&doi=10.2337%2Fdc05-2179&volume=29&pages=1130-1139&publication_year=2006&author=Abdul-Ghani%2CMA&author=Tripathy%2CD&author=DeFronzo%2CRA) 8. DeFronzo, R. A. et al. Type 2 diabetes mellitus. _Nat. Rev. Dis. Primers_ **1** , 15019 (2015). [Article](https://doi.org/10.1038%2Fnrdp.2015.19) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27189025) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=Type%202%20diabetes%20mellitus&journal=Nat.%20Rev.%20Dis.%20Primers&doi=10.1038%2Fnrdp.2015.19&volume=1&publication_year=2015&author=DeFronzo%2CRA) 9. Roden, M. & Shulman, G. I. The integrative biology of type 2 diabetes. _Nature_ **576** , 51–60 (2019). [Article](https://doi.org/10.1038%2Fs41586-019-1797-8) [CAS](https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1MXitlWku7nL) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31802013) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=The%20integrative%20biology%20of%20type%202%20diabetes&journal=Nature&doi=10.1038%2Fs41586-019-1797-8&volume=576&pages=51-60&publication_year=2019&author=Roden%2CM&author=Shulman%2CGI) 10. Lim, L
## Related Clinical Research

- [GLP-1 receptor agonists and PMOS: evidence, mechanisms, and who may benefit](https://medichelpline.com/clinical-feed/medical-news-today-0-can-glp-1s-really-help-treat-pmos-experts-answer-3-key-questions.md)
- [Konstantinos Stefanakis: Blood-based Proteomics to Detect MASLD/MASH — ENDO 2026 Audience Choice](https://medichelpline.com/clinical-feed/endocrine-news-0-star-power-2026-q-a-with-konstantinos-stefanakis-md.md)
- [Exercise Modalities for Adults with Type 2 Diabetes and Obesity: Comparative Effects on Visceral F](https://medichelpline.com/clinical-feed/frontiers-in-immunology-19-exercise-modalities-for-adults-with-type-2-diabetes-mellitus-and-obesity.md)
- [Undiagnosed type 2 diabetes presenting as DKA with hypertriglyceridemia-induced acute pancreatitis](https://medichelpline.com/clinical-feed/cmaj-1-undiagnosed-type-2-diabetes-presenting-as-diabetic-ketoacidosis-with.md)
- [Lila Dabill, PhD: Sarm1 Neural Knockout Links to Obesity Prevention — ENDO 2026 Rising Star Q&A](https://medichelpline.com/clinical-feed/endocrine-news-1-star-power-2026-q-a-with-lila-dabill-phd.md)

## Navigation
- [← Back to Endocrinology Feed](https://medichelpline.com/clinical-feed/endocrinology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.